1,416 results on '"Monteleone, Giovanni"'
Search Results
102. Overview of Role of the Immune System in the Pathogenesis of Inflammatory Bowel Disease
103. Local immune activity in acute coronary syndrome: oxLDL abrogates LPS-tolerance in mononuclear cells isolated from culprit lesion
104. Targeting IL-34/MCSF-1R Axis in Colon Cancer
105. Ustekinumab versus adalimumab for induction and maintenance therapy in biologic-naive patients with moderately to severely active Crohn's disease: a multicentre, randomised, double-blind, parallel-group, phase 3b trial
106. Mo1531: MONITORING ULCERATIVE COLITIS USING INTESTINAL ULTRASOUND
107. Su1533: ULTRASOUND AND ELASTOGRAPHY PATIENT PROFILING PREDICT SHORT-TERM CLINICAL REMISSION IN CROHN'S DISEASE
108. Tu1511: LONG-TERM RISK OF COLECTOMY OF HOSPITALIZED PATIENTS WITH SEVERE ULCERATIVE COLITIS RESPONDING TO INTRAVENOUS CORTICOSTEROIDS OR INFLIXIMAB
109. 232: EARLY ULTRASOUND ASSESSMENT PREDICTS THERAPY RESPONSE: AN EASY TOOL FOR CLINICAL DECISION MAKING
110. Tu1474: NICLOSAMIDE ENEMAS, A SAFE AND EFFECTIVE TREATMENT IN MILD TO MODERATE ULCERATIVE PROCTITIS/PROCTOSIGMOIDITIS: RESULTS FROM AN OPEN LABEL STUDY
111. Interleukin-34 Mediates Cross-Talk Between Stromal Cells and Immune Cells in the Gut
112. Smad7 antisense oligonucleotide-based therapy for inflammatory bowel diseases
113. Su1805 EARLY MONITORING TREATMENT RESPONSE IN ULCERATIVE COLITIS: A MULTICENTER STUDY
114. Sa1807 DEFINING DIAGNOSTIC ULTRASONOGRAPHIC PARAMETERS IN ULCERATIVE COLITIS: A LONGITUDINAL PROSPECTIVE MULTICENTER STUDY
115. High Smad7 sustains inflammatory cytokine response in refractory coeliac disease
116. Sodium chloride–enriched Diet Enhanced Inflammatory Cytokine Production and Exacerbated Experimental Colitis in Mice
117. Tissue Inhibitor of Metalloproteinase-3 Regulates Inflammation in Human and Mouse Intestine
118. Phylogenetic analysis of Prevotella copri from fecal and mucosal microbiota of IBS and IBD patients.
119. Smad7 Antisense Oligonucleotide in Crohn's Disease: A Re-Evaluation and Explanation for the Discordant Results of Clinical Trials.
120. Antisense Approach to Inflammatory Bowel Disease: Prospects and Challenges
121. Endoscopic Ultrasound Plus Endoscopic Retrograde Cholangiopancreatography Based Tissue Sampling for Diagnosis of Proximal and Distal Biliary Stenosis Due to Cholangiocarcinoma: Results from a Retrospective Single-Center Study
122. Long-Term Risk of Colectomy in Patients with Severe Ulcerative Colitis Responding to Intravenous Corticosteroids or Infliximab
123. Reply
124. Implication of Intestinal Barrier Dysfunction in Gut Dysbiosis and Diseases
125. Difficult Biliary Stones: A Comprehensive Review of New and Old Lithotripsy Techniques
126. Intestinal Taxa Abundance and Diversity in Inflammatory Bowel Disease Patients: An Analysis including Covariates and Confounders
127. The impact of COVID-19 on elective and urgent digestive endoscopic procedures: a report on a year of pandemic in a gastroenterology centre in Italy
128. The Tumor Suppressor Activity of IKKα in Stratified Epithelia Is Exerted in Part via the TGF-β Antiproliferative Pathway
129. Emerging immunological targets in inflammatory bowel disease
130. Long COVID in Inflammatory Bowel Diseases
131. Long-Term Outcomes and Predictive Factors of Hospitalized Patients with Severe Ulcerative Colitis Treated with Intravenous Corticosteroids
132. Tips and tricks for the diagnosis and management of biliary stenosis-state of the art review
133. Interleukin-34 Induces Cc-chemokine Ligand 20 in Gut Epithelial Cells
134. Aryl hydrocarbon receptor and colitis
135. Interleukin-25: A two-edged sword in the control of immune-inflammatory responses
136. Inhibition of Colon Carcinogenesis by 2-Methoxy-5-Amino-N-Hydroxybenzamide, a Novel Derivative of Mesalamine
137. Efficacy of hemostatic powders as monotherapy or rescue therapy in gastrointestinal bleeding related to neoplastic or non-neoplastic lesions
138. GATA6 Deficiency Leads to Epithelial Barrier Dysfunction and Enhances Susceptibility to Gut Inflammation
139. Efficacy and tolerability of very low-volume bowel preparation in patients with inflammatory bowel diseases
140. Mongersen, an Oral SMAD7 Antisense Oligonucleotide, and Crohnʼs Disease
141. Inhibition of monocyte-derived inflammatory cytokines by IL-25 occurs via p38 Map kinase–dependent induction of Socs-3
142. Metalloproteinases in Inflammatory Bowel Diseases
143. Interleukin-21 (IL-21)-mediated pathways in T cell-mediated disease
144. The Role of IL-21 in Chronic Inflammatory Skin Diseases
145. A Healthy Gut for a Healthy Brain: Preclinical, Clinical and Regulatory Aspects
146. Sa458 CLINICAL RELEVANCE OF ULTRASONOGRAPHIC LESIONS IN CROHN'S DISEASE
147. Precision Medicine in Inflammatory Bowel Diseases
148. Involvement of Smad7 in Inflammatory Diseases of the Gut and Colon Cancer
149. Aberrant expression of the Th2 cytokine IL-21 in Hodgkin lymphoma cells regulates STAT3 signaling and attracts Treg cells via regulation of MIP-3α
150. Th17 immune response in IBD: A new pathogenic mechanism
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.